MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,000K
Net Income
-$18,990K
Net Profit Margin
-1899.00%
EPS
-$0.13
Unit: Thousand (K) dollars
Revenue Breakdown
License
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenue
1,000
0
-
122
Total revenue-Research And Development Services
-
0
-
-
Research and development
9,601
9,923
7,837
14,828
General and administrative
8,157
13,175
17,688
15,037
Total costs and expenses
17,758
23,098
25,525
29,865
Loss from operations
-16,758
-23,098
-25,525
-29,743
Interest income
144
364
621
1,357
Change in fair value of warrant liabilities
2,369
-1,437
-3,104
40,184
Other expense
-7
-33
-25
-21
Total other income (expense), net
-2,232
1,768
3,700
-38,848
Net loss
-18,990
-21,330
-21,825
-68,591
Basic EPS
-0.13
-0.15
-0.15
-0.48
Diluted EPS
-0.13
-0.15
-0.15
-0.48
Basic Average Shares
145,559,604
145,091,474
144,787,971
144,345,781
Diluted Average Shares
145,559,604
145,091,474
144,787,971
144,345,781
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$18,990K
(72.31%↑ Y/Y)
License
$1,000K
Loss from operations
-$16,758K
(43.66%↑ Y/Y)
Total other income
(expense), net
-$2,232K
(94.25%↑ Y/Y)
Total revenue
$1,000K
(719.67%↑ Y/Y)
Interest income
$144K
(-89.39%↓ Y/Y)
Total costs and
expenses
$17,758K
(-40.54%↓ Y/Y)
Change in fair value of
warrant liabilities
$2,369K
(-94.10%↓ Y/Y)
Other expense
-$7K
(66.67%↑ Y/Y)
Research and development
$9,601K
(-35.25%↓ Y/Y)
General and
administrative
$8,157K
(-45.75%↓ Y/Y)
Buy us a coffee
Applied Therapeutics, Inc. (APLT)
Applied Therapeutics, Inc. (APLT)